SeminarNon-melanoma skin cancer
Introduction
The term non-melanoma skin cancers (or keratinocyte carcinomas) encompasses cutaneous lymphomas, adnexal tumours, Merkel-cell carcinomas, and other rare primary cutaneous neoplasms, but is mainly used to define basal-cell carcinomas and squamous-cell carcinomas. Grouping of these two carcinomas under a common umbrella term poses challenges, because clear differences exist in their aetiopathogenesis, clinical course, and management strategies. Non-melanoma skin cancers are the most common human cancers, and despite growing public awareness of the harmful effects of sun exposure, incidence continues to rise.1, 2 A 3–8% yearly increase in incidence of non-melanoma skin cancer has been reported since 1960 worldwide.3, 4 Incidence of basal-cell carcinoma alone is increasing by 10% per year worldwide, suggesting that prevalence of this tumour will soon equal that of all other cancers combined.5 Furthermore, an estimated 40–50% of patients with a primary carcinoma will develop at least one or more further basal-cell carcinomas within 5 years. The estimated incidence of non-melanoma skin cancer in the USA is more than 1 000 000 cases per year, of which roughly 20–30% are of squamous-cell carcinoma.6
Section snippets
Epidemiology
Unfortunately, because of variation between registries in data capture, recording, and processing for skin-cancer registration, accurate figures for incidence of non-melanoma skin cancer in the UK are difficult to obtain.7 More than 76 000 new cases of non-melanoma skin cancer were registered in the UK in 2005, but the actual incidence is estimated to be at least 100 000 cases per year.8 Results of a Welsh study9 showed that the crude incidence of non-melanoma skin cancer increased from 173·5
Pathogenesis
UVB radiation causes direct damage to DNA and RNA by inducing covalent bond formation between adjacent pyrimidines, leading to generation of mutagenic photoproducts such as cyclopyrimidine dimers (TT) and pyrimidine-pyrimidine (6-4) adducts.25 UVA is less mutagenic than is UVB, and causes indirect DNA damage via a photo-oxidative-stress-mediated mechanism, resulting in formation of reactive oxygen species, which interact with lipids, proteins, and DNA to generate intermediates that combine with
Diagnosis
Early basal-cell carcinomas are usually small, translucent, or pearly, with raised telangiectatic edges. Roughly 80% of all basal-cell carcinomas occur on the head and neck, and clinical diagnosis is fairly straightforward.72 In addition to the classic rodent ulcer with an indurated edge and ulcerated centre, nodular or cystic, superficial, morphoeic, and pigmented basal-cell carcinomas are other common subtypes (figure 3). 10–40% of basal-cell carcinomas contain a mixed pattern of two or more
Prognosis and staging
Non-melanoma skin cancers, especially basal-cell carcinomas, have low metastatic potential and are associated with low mortality. The likelihood of metastases and recurrence of squamous-cell and basal-cell carcinoma depends on several prognostic indicators (table 4).86, 89, 90, 91 These indicators draw attention to the importance of a detailed pathological description, since individual lesion and host characteristics have to be taken into account when determining the prognosis of non-melanoma
Management
The British Association of Dermatologists has issued guidelines for management of non-melanoma skin cancers.86, 98 Interventions for management of basal-cell carcinomas in immunocompetent patients and prevention of non-melanoma skin cancers in high-risk groups have been systematically reviewed.99, 100 Routine use of sunscreen might prevent squamous-cell carcinoma, but is of unproven benefit in basal-cell carcinoma.101 Several government and charitable organisations have launched prevention
References (155)
- et al.
Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973
J Invest Dermatol
(2004) - et al.
Basal cell carcinoma on the trunk is associated with excessive sun exposure
J Am Acad Dermatol
(2007) - et al.
The health impact of solar radiation and prevention strategies: report of the Environment Council, American Academy of Dermatology
J Am Acad Dermatol
(1999) - et al.
Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors
J Invest Dermatol
(1998) - et al.
Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles
J Invest Dermatol
(2008) How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: the role of cellular damage responses
J Invest Dermatol
(2007)- et al.
Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals
J Invest Dermatol
(2008) - et al.
Beta-papillomavirus infection and skin cancer
J Invest Dermatol
(2008) - et al.
Cutaneous malignancy and human immunodeficiency virus disease
J Am Acad Dermatol
(2006) - et al.
PUVA and cancer: a large-scale epidemiological study
Lancet
(1991)
Reported use of photosensitizing medications and basal cell and squamous cell carcinoma of the skin: results of a population-based case-control study
J Invest Dermatol
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome
Cell
Allelic loss at Drosophila patched gene is highly prevalent in basal and squamous cell carcinomas of the skin
J Invest Dermatol
Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair
Am J Hum Genet
p53 and the pathogenesis of skin cancer
Toxicol Appl Pharmacol
Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient
J Invest Dermatol
Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia
Hum Pathol
Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms
J Am Acad Dermatol
Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma
Br J Plast Surg
Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study
Lancet Oncol
Skin cancer of the head and neck with clinical perineural invasion
Int J Radiat Oncol Biol Phys
Time to rethink TNM staging in cutaneous SCC
Lancet Oncol
The epidemiology of skin cancer
Br J Dermatol
Skin cancer trends in Northern Ireland and consequences for provision of dermatology services
Br J Dermatol
Changing patterns in incidence of nonmelanoma skin cancer
Epithelial Cell Biol
The emerging epidemic of melanoma and squamous cell skin cancer
JAMA
Unresolved issues in the epidemiology of basal cell and squamous cell skin cancer
Detailed guide: skin cancer–basal and squamous cell
Variations in registration of skin cancer in the United Kingdom
Clin Exp Dermatol
CancerStats Key facts on skin cancer. How common is skin cancer?
Changing trends in non-melanoma skin cancer in South Wales, 1988–98
Br J Dermatol
Skin cancer incidence and the ageing population
Br J Dermatol
Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer)
Br J Dermatol
Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985
Med J Aust
Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992–2003
Br J Dermatol
Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001
J Cutan Med Surg
Sunlight and cancer
Cancer Causes Control
Incidence of non-melanoma skin cancer in the United States. NIH Pub No 82-2433
A dose-response curve for sun exposure and basal cell carcinoma
Int J Cancer
Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia
Int J Cancer
The multicentre south European study “Helios” II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin
Br J Cancer
Cellular and sub-cellular responses to UVA in relation to carcinogenesis
Int J Radiat Biol
Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy
Br J Dermatol
Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals
J Med Virol
Human papillomavirus infections in non melanoma skin cancers from renal transplant recipients and non immunosuppressed patients
J Natl Cancer Inst
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin
J Natl Cancer Inst
Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy
Arch Dermatol
Incidence of skin cancer in 5356 patients following organ transplantation
Br J Dermatol
The role of immunosuppression in the pathogenesis of basal cell carcinoma
Br J Dermatol
A population-based study of skin cancer incidence and prevalence in renal transplant recipients
Br J Dermatol
Cited by (681)
Nanotechnology strategies to address challenges in topical and cellular delivery of siRNAs in skin disease therapy
2024, Advanced Drug Delivery ReviewsTargeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer
2024, Journal of Advanced ResearchTopical delivery of nanoemulsions for skin cancer treatment
2023, Applied Materials Today